European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
A retrospective analysis of borderline ovarian tumors in a Greek University Hospital
1 2nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Aretaieion Hospital, Athens (Greece)
Eur. J. Gynaecol. Oncol. 2008, 29(4), 383–385;
Published: 10 August 2008
Purpose: The aim of this retrospective study was to analyze the pathologic and clinical characteristics of borderline ovarian tumors. Methods/Results: During the period from January 1993 up to December 2002 we found 93 cases of borderline ovarian tumors. The mean age of patients was 44.3 years (range 28.9-59.7 years); 77.4%, 10.8% and 11.8% of patients had Stage I, II and III, respectively. The histological outcomes revealed 52.7% of serous and 41.9% of mucinous origin; 44.1% underwent radical surgery, whereas 55.9% had unilateral salpingo-oophorectomy or cystectomy. The mean follow-up was 84 ± 22 months. The overall five-year survival was 97.4% and 98% for mucinous and serous tumors, respectively. The survival rate was 100%, 90% and 81.8% in Stages I, II and III, respectively. Conclusion: From our results it can be concluded that borderline ovarian tumors have a favorable prognosis even after conservative management.
Borderline ovarian tumors
Low malignant pote